|
STAB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.875000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.084600E-01 |
| Normal-vs-Stage2 |
2.863000E-01 |
| Normal-vs-Stage3 |
4.644600E-01 |
| Normal-vs-Stage4 |
6.042000E-01 |
| Stage1-vs-Stage2 |
2.877800E-01 |
| Stage1-vs-Stage3 |
4.032400E-01 |
| Stage1-vs-Stage4 |
7.115600E-01 |
| Stage2-vs-Stage3 |
7.491200E-01 |
| Stage2-vs-Stage4 |
2.495200E-01 |
| Stage3-vs-Stage4 |
4.071200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.825800E-01 |
| Normal-vs-AfricanAmerican |
7.310200E-01 |
| Normal-vs-Asian |
8.568800E-01 |
| Caucasian-vs-AfricanAmerican |
3.038200E-01 |
| Caucasian-vs-Asian |
8.808400E-01 |
| AfricanAmerican-vs-Asian |
7.467400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.553600E-01 |
| Normal-vs-Female |
6.048600E-01 |
| Male-vs-Female |
7.794600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.024800E-01 |
| Normal-vs-Extreme_Weight |
4.765200E-01 |
| Normal-vs-Obese |
4.128800E-01 |
| Normal-vs-Extreme_Obese |
9.780000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.205200E-01 |
| Normal_Weight-vs-Obese |
1.210850E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.387400E-01 |
| Extreme_Weight-vs-Obese |
1.598150E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.481400E-01 |
| Obese-vs-Extreme_Obese |
7.935600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.235200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.251400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.340200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.378200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.782200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.487000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.672200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.155800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.909200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.575000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.750400E-01 |
| Normal-VS-Type2 PRCC |
8.352800E-01 |
| Normal-VS-KIRP CIMP |
4.614000E-01 |
| Normal-VS-Unclassified PRCC |
3.043500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.330800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.552600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.820300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
7.747600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.934000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.010200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.578400E-01 |
| Normal-vs-N1 |
5.434000E-01 |
| Normal-vs-N2 |
5.016800E-01 |
| N0-vs-N1 |
8.352800E-01 |
| N0-vs-N2 |
7.590800E-01 |
| N1-vs-N2 |
8.777200E-01 |
|
|
